Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Capecitabine|DRUG: S-1
Sponsor: Japan Breast Cancer Research Network